Press Releases
DHL Global Forwarding launches innovative one-stop customer portal for digital logistics
DHL Global Forwarding, Deutsche Post DHL Group’s air and ocean freight specialist, has launched myDHLi, the only fully integrated online platform for freight forwarding customers. myDHLi’s highly intuitive user interface makes it easy to use and ensures that customers...
Press Releases
WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States
WuXi Biologics, a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced the successful signing of a land deal for WuXi Biologics’ clinical and commercial manufacturing facility (MFG11) in Worcester at The...
Press Releases
Triphase, Catalent Announce Interim TRPH-222 Results in NHL
Triphase Accelerator and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced interim results for Triphase Accelerator’s multi-center, open-label, monotherapy study of TRPH-222...
Packaging & Labelling
Pharmapack expert recommends holistic approach to sustainability
In an in-depth review of the market and having evaluated the collective developments from this year’s Pharmapack event, Gregor Anderson – MD of Pharmacentric Solutions – offers a positive appraisal of pharma’s drive towards sustainability.
“I am really encouraged by...
Press Releases
Thermo Fisher Support of COVID-19 Response Continues to Expand with U.S. Government Contract for Products Used in Sample Collection
Thermo Fisher Scientific Inc., the world leader in serving science, announced it has received a contract from the U.S. government to provide highly specialized viral transport media (VTM) for COVID-19 sample collection. The VTM is used during collection of...
Press Releases
FDA approves Roche’s Tecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancer
Roche announced that the US FDA has approved Tecentriq as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells or PD-L1...
Press Releases
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test
Duke-NUS Medical School (Duke-NUS), a research intensive graduate-entry medical school, GenScript Biotech Corporation, a leading global biotechnology company, and the Diagnostics Development Hub (DxD) at Singapore's Agency for Science, Technology and Research (A*STAR), announced an exclusive agreement to co-develop...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read